Silvana Geracitano

549 total citations
18 papers, 232 citations indexed

About

Silvana Geracitano is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Silvana Geracitano has authored 18 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Silvana Geracitano's work include Alzheimer's disease research and treatments (6 papers), Epigenetics and DNA Methylation (4 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Silvana Geracitano is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Epigenetics and DNA Methylation (4 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Silvana Geracitano collaborates with scholars based in Italy, Georgia and Saudi Arabia. Silvana Geracitano's co-authors include Alberto Montesanto, Raffaele Maletta, Giuseppe Passarino, Amalia C. Bruni, Carmine Tomaino, Maura Gallo, Livia Bernardi, Rosanna Colao, Francesca Frangipane and Sabrina A.M. Curcio and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Silvana Geracitano

17 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvana Geracitano Italy 11 111 104 50 38 29 18 232
Duc M. Duong United States 8 108 1.0× 77 0.7× 22 0.4× 48 1.3× 31 1.1× 16 245
Nadia V. Harerimana United States 5 122 1.1× 79 0.8× 17 0.3× 67 1.8× 29 1.0× 9 238
Lesley Leong United States 8 187 1.7× 132 1.3× 22 0.4× 63 1.7× 34 1.2× 9 300
Maura Gallo Italy 9 82 0.7× 103 1.0× 63 1.3× 28 0.7× 40 1.4× 13 174
Vincent Huin France 10 100 0.9× 70 0.7× 67 1.3× 29 0.8× 47 1.6× 19 232
Tamao Tsukie Japan 11 184 1.7× 224 2.2× 63 1.3× 76 2.0× 47 1.6× 18 375
MHD Rami Al Shweiki Germany 8 141 1.3× 55 0.5× 62 1.2× 19 0.5× 34 1.2× 10 332
Elin Byman Sweden 10 61 0.5× 119 1.1× 35 0.7× 19 0.5× 93 3.2× 10 253
Martin Medrano United States 8 164 1.5× 179 1.7× 20 0.4× 108 2.8× 19 0.7× 13 324
Alon Friedman Israel 8 94 0.8× 59 0.6× 25 0.5× 12 0.3× 41 1.4× 11 293

Countries citing papers authored by Silvana Geracitano

Since Specialization
Citations

This map shows the geographic impact of Silvana Geracitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Geracitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Geracitano more than expected).

Fields of papers citing papers by Silvana Geracitano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Geracitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Geracitano. The network helps show where Silvana Geracitano may publish in the future.

Co-authorship network of co-authors of Silvana Geracitano

This figure shows the co-authorship network connecting the top 25 collaborators of Silvana Geracitano. A scholar is included among the top collaborators of Silvana Geracitano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvana Geracitano. Silvana Geracitano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bruno, Francesco, et al.. (2025). Reproducibility and validation of a targeted and flexible epigenetic clock for forensic applications. Forensic Science International. 369. 112409–112409. 1 indexed citations
2.
Lagani, Vincenzo, Silvana Geracitano, Luigi Citrigno, et al.. (2023). An ELOVL2-Based Epigenetic Clock for Forensic Age Prediction: A Systematic Review. International Journal of Molecular Sciences. 24(3). 2254–2254. 14 indexed citations
3.
Geracitano, Silvana, Vincenzo Lagani, Patrizia D’Aquila, et al.. (2022). A Blood-Based Molecular Clock for Biological Age Estimation. Cells. 12(1). 32–32. 10 indexed citations
4.
Lagani, Vincenzo, et al.. (2022). A new approach to broaden the range of eye colour identifiable by IrisPlex in DNA phenotyping. Scientific Reports. 12(1). 12803–12803. 4 indexed citations
5.
Geracitano, Silvana, Vincenzo Lagani, Luca Soraci, et al.. (2022). Clinical and Prognostic Implications of Estimating Glomerular Filtration Rate by Three Different Creatinine-Based Equations in Older Nursing Home Residents. Frontiers in Medicine. 9. 870835–870835. 3 indexed citations
6.
Montesanto, Alberto, Patrizia D’Aquila, Vincenzo Lagani, et al.. (2020). A New Robust Epigenetic Model for Forensic Age Prediction. Journal of Forensic Sciences. 65(5). 1424–1431. 30 indexed citations
7.
Crocco, Paolina, Alberto Montesanto, Serena Dato, et al.. (2019). Inter-Individual Variability in Xenobiotic-Metabolizing Enzymes: Implications for Human Aging and Longevity. Genes. 10(5). 403–403. 15 indexed citations
8.
Montesanto, Alberto, Paolina Crocco, Serena Dato, et al.. (2018). Uncoupling protein 4 (UCP4) gene variability in neurodegenerative disorders: further evidence of association in Frontotemporal dementia. Aging. 10(11). 3283–3293. 10 indexed citations
9.
Montesanto, Alberto, Daniela Pellegrino, Silvana Geracitano, et al.. (2018). Cardiovascular risk profiling of long‐lived people shows peculiar associations with mortality compared with younger individuals. Geriatrics and gerontology international. 19(2). 165–170. 4 indexed citations
10.
Montesanto, Alberto, Silvana Geracitano, Sabrina Garasto, et al.. (2016). The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence. Current Drug Targets. 17(4). 428–438. 3 indexed citations
11.
Cizza, Giovanni, Livia Bernardi, Nicoletta Smirne, et al.. (2011). Clinical Manifestations of Highly Prevalent Corticosteroid-Binding Globulin Mutations in a Village in Southern Italy. The Journal of Clinical Endocrinology & Metabolism. 96(10). E1684–E1693. 21 indexed citations
12.
Anfossi, Maria, Romina Vuono, Raffaele Maletta, et al.. (2011). Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia. Neurobiology of Aging. 32(4). 757.e1–757.e11. 16 indexed citations
13.
Bernardi, Livia, Maria Anfossi, Maura Gallo, et al.. (2011). PSEN1 and PRNP Gene Mutations Co-occurrence Makes Onset Very Early in a Family with FTD Phenotype. Journal of Alzheimer s Disease. 24(3). 415–419. 8 indexed citations
14.
Anfossi, Maria, Livia Bernardi, Maura Gallo, et al.. (2010). MAPT V363I Variation in a Sporadic Case of Frontotemporal Dementia. Alzheimer Disease & Associated Disorders. 25(1). 96–99. 12 indexed citations
15.
Gallo, Maura, Carmine Tomaino, Gianfranco Puccio, et al.. (2009). Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurological Sciences. 31(1). 65–70. 17 indexed citations
16.
Bernardi, Livia, Silvana Geracitano, Rosanna Colao, et al.. (2009). AβPP A713T Mutation in Late Onset Alzheimer's Disease with Cerebrovascular Lesions. Journal of Alzheimer s Disease. 17(2). 383–389. 17 indexed citations
17.
Bruni, Amalia C., Francesca Frangipane, Rosanna Colao, et al.. (2009). P3‐166: Epidemiology of Frontotemporal dementia in southern Italy. Alzheimer s & Dementia. 5(4S_Part_13). 1 indexed citations
18.
Bernardi, Livia, Carmine Tomaino, Maria Anfossi, et al.. (2008). Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia. Neurobiology of Aging. 30(11). 1825–1833. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026